Electrophysiology catheters market seen reaching $13.83 billion by 2030

The electrophysiology catheters market is forecast to grow from $8.55 billion in 2026 to $13.83 billion by 2030, driven by rising heart rhythm disorders, more catheter ablation procedures and expanding cardiac care capacity. North America leads today, while Asia-Pacific and Southeast Asia are set for faster growth as healthcare systems and cardiology investment expand.

Why it matters: - The electrophysiology catheters market sits at the center of cardiac rhythm diagnosis and treatment. - Rising demand for minimally invasive cardiac procedures is expanding use of mapping and ablation tools in hospitals and specialty labs. - Growth in this market tracks broader demand for cardiac care as cardiovascular disease remains a major cause of death.

What happened: - The Business Research Company released a 2026 market report on electrophysiology catheters. - The market is projected to rise from $7.58 billion in 2025 to $8.55 billion in 2026. - The report forecasts the market will reach $13.83 billion by 2030. - The report uses a 12.8% compound annual growth rate for both the 2026 and 2030 outlooks. - The report includes a free sample and a full report link: More information and the full report.

The details: - Electrophysiology catheters are used to diagnose and treat heart rhythm abnormalities. - The catheters are threaded through blood vessels into the heart to record electrical signals, map electrical pathways and deliver ablation therapy. - Procedures typically take place in specialized electrophysiology labs in hospitals or clinical settings. - Historical growth was driven by more cardiac arrhythmia cases, more hospital electrophysiology labs, wider adoption of catheter ablation, stronger cardiology infrastructure and better physician expertise. - Future growth is expected to come from an aging population, more ambulatory cardiac care centers, higher awareness of arrhythmia management and greater healthcare spending on cardiac services. - The report flags stronger use of catheter-based arrhythmia therapies, advanced cardiac mapping catheters, high-precision ablation catheters and higher procedure volumes in dedicated electrophysiology labs. - The market covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific and Southeast Asia are expected to grow fastest.

Between the lines: - The market outlook points to a shift toward more specialized, technology-heavy cardiac procedures. - The forecast suggests hospitals and ambulatory centers will keep adding capacity as arrhythmia treatment moves toward minimally invasive care. - The report's regional split highlights a mature market in North America and faster adoption potential in emerging Asian markets. - The CDC reported in October 2024 that cardiovascular disease caused 919,032 deaths in the United States in 2023, or about one in three deaths.

What's next: - The report says its 2026 editions now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspot infographics. - Continued growth will likely depend on cardiovascular disease prevalence, healthcare infrastructure investment and adoption of advanced electrophysiology tools. - More procedure volume at dedicated electrophysiology labs is expected as cardiac care expands.

The bottom line: - Electrophysiology catheters are moving from a niche specialty tool to a larger growth market tied to the global burden of heart rhythm disorders and the push for less invasive cardiac care.